Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, single-dose, dose escalation study in
healthy male and or female subjects and subjects with Rheumatoid Arthritis (RA) to determine
the safety and tolerability of MORAb-022.